Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1R34HL174885-01 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
This project will develop and test a novel clinical decision support tool (CDS) that encourages timely referral to palliative care for people hospitalized with heart failure. This intervention will incorporate an existing, validated 1-year mortality risk model into a CDS to deliver prognostic information and evidence-based decision support at the point of care. Thus, this research may lead to improved care-concordant and goal-directed care for people with heart failure.
Healthcare providers will encounter the tool during the routine care of their hospitalized patients. Patients randomized to the intervention arm will have providers who receive the tool and can complete one post-trial survey. High use providers will also have the opportunity to participate in a survey and 1 post-trial interview. Level 2 providers will participate in one interview.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Clinical Decision Support (CDS) Tool | Experimental | Patients will be randomized to have the CDS tool to deliver prognostic information and evidence-based decision support at the point of care for timely referral to palliative care for participants hospitalized with heart failure. |
|
| Standard of Care | No Intervention | Providers will provide usual standard of care for participants hospitalized with heart failure. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Clinical Decision Support Tool | Behavioral | Deliver prognostic information and evidence-based decision support at the point of care |
|
| Measure | Description | Time Frame |
|---|---|---|
| Mean System Usability Scale score | System Usability Scale, 10-item Likert questionnaire. Total score range 0-100. Higher values indicate higher usability | up to 15 months |
| Mean Acceptability of Intervention Measure score | Acceptability of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher acceptability. | up to 15 months |
| Mean Appropriateness of Intervention Measure score | Appropriateness of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher appropriateness. | up to 15 months |
| Mean Feasibility of Intervention Measure score | Feasibility of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher feasibility. | up to 15 months |
| Measure | Description | Time Frame |
|---|---|---|
| Referral to Specialist Palliative Care | Proportion of participants who are referred to Specialist Palliative Care | up to 15 months |
| Consultation by Specialist Palliative Care | Proportion of participants who have a completed consultation order by Specialist Palliative Care |
Not provided
Inclusion Criteria:
Healthcare providers must meet the following criteria:
Or
Patients of providers enrolled in the study must meet the following criteria for heart failure during hospitalization:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Shelli Feder, PhD | Contact | 937-239-2801 | shelli.feder@yale.edu | |
| Nathan Wright, MA | Contact | nathan.wright@yale.edu |
| Name | Affiliation | Role |
|---|---|---|
| Shelli Feder, PhD | Yale University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Yale New Haven Hospital Saint Raphael | New Haven | Connecticut | 06520 | United States | ||
| Yale New Haven Hospital York Street |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Eligibility of patients will be assessed automatically by an existing Epic build and will not involve any human intervention. When a provider opens the order entry screen of the patient's medical record, this build will examine the record for all inclusion and exclusion criteria. Those who meet criteria will be automatically enrolled and placed into a randomization group based on the randomization status of their current provider at the time of enrollment. Target sample size is 70 Level 1 providers, 2260 participants and 15 Level 2 providers (providers potentially impacted by the tool).
Not provided
Not provided
Not provided
Not provided
| up to 15 months |
| Advance Care Plan Documentation | Proportion of participants who have a documented Advance Care Plan | up to 15 months |
| Participants enrolled in hospice | Proportion of participants enrolled in hospice during hospitalization | up to 15 months |
| Mean hospital length of stay | Mean hospital length of stay in days | up to 15 months |
| Participants readmitted to hospital | Proportion of participants with 30-day hospital readmission | up to 15 months |
| Change in Code Status | Change in code status for comfort measures | up to 15 months |
| New Haven |
| Connecticut |
| 06520 |
| United States |